Why so much medical technoskepticism ?
Arlen Meyers, MD, MBA
President and CEO, Society of Physician Entrepreneurs, another lousy golfer, terrible cook, friction fixer
Medicine has transitioned from high touch to high tech to low trust. The explosion of post COVID technology "innovations" is leaving a wake of skepticism from the healing class.
As noted, Covid-19 let virtual medicine out of the bottle. Now it’s time to tame it. If we don’t, there is a danger that it will stealthily become a mainstay of our medical care. Deploying it too widely or too quickly risks poorer care, inequities and even more outrageous charges in a system already infamous for big bills.
The techno-optimists think technology is the solution. Technosckeptics think it is the problem.
Medical technoscepticism is driven by:
领英推荐
High cost, low value digital health technologies are not alone. Is robotic surgery really better?
The pandemic spurred a huge increase in the use of virtual health care. But its place in the post-pandemic world is up in the air. To help policymakers, payers, providers assess the??various ways in which virtual care programs could have a positive impact for patients, clinicians, payers, and society going forward, the American Medical Association and Manatt Health developed a framework. It can be used by care providers to develop and evaluate new digitally-enabled-care models, by payers to inform coverage and payment decisions, and by policymakers to establish regulations.
Much like confronting COVID vaccine skepticism, addressing technoskepticism will require a multipronged approach. We are not fighting the battle alone. Maybe you should just take your worthless vitamins and supplements and forget about all that technology.
Arlen Meyers, MD, MBA is the President and CEO of the Society of Physician Entrepreneurs on Substack and Editor of Digital Health Entrepreneurship
Father, Husband, Women's Health Advocate, CEO, Co-Founder at Mother Goose Health
3 年Totally accurate commentary Arlen. There is a huge divide between what is good for investors and what is good for patients.
Founder & CEO | Chief Scientific Officer | French Tech Nordics | C-Suite Coach & Advisor | Intercultural Management Expert
3 年Well analyzed Arlen Meyers, MD, MBA ! Fully agree with the fact that restoring trust and interest requires a solid, multidimensional and qualified approach. But honestly I understand the skepsis of health professionals vs opportunistic, greedy, money only obsessed new health tech ventures. Strong Ethics will be the only way to solve the equation / reduce skepsis. Thank you Avneesh Khare, MD, MBA for sharing !